antipsychotic agents

Preferred Label : antipsychotic agents;

MeSH definition : Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.;

MeSH synonym : major tranquilizing agents; tranquillizing agents, major; neuroleptics; major tranquillizing agents; tranquilizing agents, major; major tranquilizers; antipsychotics; antipsychotic drugs; neuroleptic drugs; neuroleptic agents; Antipsychotic Agent; Agent, Antipsychotic; Neuroleptic; Antipsychotic; Major Tranquilizer; Tranquilizer, Major; Antipsychotic Drug; Drug, Antipsychotic; Neuroleptic Agent; Agent, Neuroleptic; Neuroleptic Drug; Drug, Neuroleptic; Antipsychotic Medication; Medication, Antipsychotic;

CISMeF synonym : agents, antipsychotic; agents, major tranquilizing; agents, major tranquillizing; agents, neuroleptic; drugs, antipsychotic; drugs, neuroleptic; tranquilizers, major;

Related MeSH term : antipsychotic effect; Effect, Antipsychotic; Antipsychotic Effects; Effects, Antipsychotic;

MeSH annotation : note entry term ANTIPSYCHOTIC EFFECT: use only for the antipsychotic effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Antipsychotic;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D014150;

UMLS CUI

C0040615;

ATC code(s)
- lithium [ATC Code]
- moperone [ATC Code]
- periciazine [ATC Code]
- prothipendyl [ATC Code]
- thiopropazate [ATC Code]
- thioproperazine [ATC Code]
ATC code(s)
- acepromazine [ATC Code]
- acetophenazine [ATC Code]
- amisulpride [ATC Code]
- antipsychotics [ATC Code]
- aripiprazole [ATC Code]
- asenapine [ATC Code]
- benperidol [ATC Code]
- benzamides [ATC Code]
- bromperidol [ATC Code]
- butaperazine [ATC Code]
- chlorproethazine [ATC Code]
- chlorpromazine [ATC Code]
- chlorprothixene [ATC Code]
- clopenthixol [ATC Code]
- clotiapine [ATC Code]
- clozapine [ATC Code]
- cyamemazine [ATC Code]
- dixyrazine [ATC Code]
- droperidol [ATC Code]
- fluanisone [ATC Code]
- fluoxetine and psycholeptics [ATC Code]
- fluphenazine [ATC Code]
- fluspirilene [ATC Code]
- haloperidol [ATC Code]
- levomepromazine [ATC Code]
- levosulpiride [ATC Code]
- lithium [ATC Code]
- loxapine [ATC Code]
- melperone [ATC Code]
- mesoridazine [ATC Code]
- molindone [ATC Code]
- mosapramine [ATC Code]
- olanzapine [ATC Code]
- other antipsychotics [ATC Code]
- oxypertine [ATC Code]
- paliperidone [ATC Code]
- penfluridol [ATC Code]
- perazine [ATC Code]
- perphenazine [ATC Code]
- pimozide [ATC Code]
- pipamperone [ATC Code]
- prochlorperazine [ATC Code]
- promazine [ATC Code]
- quetiapine [ATC Code]
- remoxipride [ATC Code]
- risperidone [ATC Code]
- sertindole [ATC Code]
- sulpiride [ATC Code]
- sultopride [ATC Code]
- thioridazine [ATC Code]
- tiapride [ATC Code]
- tiotixene [ATC Code]
- trifluoperazine [ATC Code]
- trifluperidol [ATC Code]
- triflupromazine [ATC Code]
- veralipride [ATC Code]
- ziprasidone [ATC Code]
- zotepine [ATC Code]
- zuclopenthixol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antipsychotics [neuroleptics] [ICHI section]
- Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified [ICD-10 category (who)]
- Poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, undetermined intent [ICD-10 category (who)]
- other antipsychotics [ATC Code]
CISMeF manual mappings
- Antipsychotics [neuroleptics] [Bloc CIM-11]
- Neuroleptic poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Anti-psychotic agent (substance) [SNOMED CT concept]
- Antipsychotic Agent [NCIt concept]
- Antipsychotics [LOINC component]
- anti-psychotic agent, nos [SNOMED Notion]
- antipsychotics [Disease (Nov.)]
- antipsychotics [ATC Code]
False automatic mappings
- Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified [ICD-10 category (who)]
Indexing information
- 7-(4-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)butoxy)-4-methyl-8-chloro-2H-chromen-2-one [MeSH Supplementary Concept]
- 8-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-1-thia-4,8-diazaspiro(4.5)decan-3-one [MeSH Supplementary Concept]
- bifeprunox [MeSH Supplementary Concept]
- cyamemazine [MeSH Supplementary Concept]
Record concept(s)
- antipsychotic agents [MeSH concept]
- antipsychotic effect [MeSH concept]
See also
- butyrophenones [MeSH Descriptor]
- dopamine antagonists [MeSH Descriptor]
- phenothiazines [MeSH Descriptor]
See also (suggested by CISMeF)
- neuroleptanalgesia [MeSH Descriptor]
- neuroleptic malignant syndrome [MeSH Descriptor]
- psychotic disorders [MeSH Descriptor]
See also inter- (CISMeF)
- Medicinal product acting as antipsychotic agent (product) [SNOMED CT concept]
- Neuroleptic adverse reaction (disorder) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol [MeSH Supplementary Concept]
- 3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine [MeSH Supplementary Concept]
- Amisulpride [MeSH Descriptor]
- Aripiprazole [MeSH Descriptor]
- Asenapine [MeSH Supplementary Concept]
- DN 1417 [MeSH Supplementary Concept]
- DuP 734 [MeSH Supplementary Concept]
- Lamotrigine [MeSH Descriptor]
- Lurasidone Hydrochloride [MeSH Descriptor]
- N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride [MeSH Supplementary Concept]
- Olanzapine [MeSH Descriptor]
- Paliperidone Palmitate [MeSH Descriptor]
- Quetiapine Fumarate [MeSH Descriptor]
- RP5063 [MeSH Supplementary Concept]
- Ro 22-1319 [MeSH Supplementary Concept]
- SK&F 10047 [MeSH Supplementary Concept]
- SR 142801 [MeSH Supplementary Concept]
- acepromazine [MeSH Descriptor]
- aceprometazine [MeSH Supplementary Concept]
- amitriptyline, perphenazine drug combination [MeSH Supplementary Concept]
- amperozide [MeSH Supplementary Concept]
- aripiprazole lauroxil [MeSH Supplementary Concept]
- azaperone [MeSH Descriptor]
- benperidol [MeSH Descriptor]
- bromperidol [MeSH Supplementary Concept]
- bromperidol decanoate [MeSH Supplementary Concept]
- butaclamol [MeSH Descriptor]
- cariprazine [MeSH Supplementary Concept]
- chlorpromazine [MeSH Descriptor]
- chlorprothixene [MeSH Descriptor]
- clopenthixol [MeSH Descriptor]
- clopenthixol acetate ester [MeSH Supplementary Concept]
- clopenthixol decanoate [MeSH Supplementary Concept]
- clothiapine [MeSH Supplementary Concept]
- clozapine [MeSH Descriptor]
- clozapine N-oxide [MeSH Supplementary Concept]
- dapiprazole [MeSH Supplementary Concept]
- dicarbine [MeSH Supplementary Concept]
- dixyrazine [MeSH Supplementary Concept]
- droperidol [MeSH Descriptor]
- ecopipam [MeSH Supplementary Concept]
- etazolate [MeSH Descriptor]
- fananserin [MeSH Supplementary Concept]
- fencamfamine [MeSH Supplementary Concept]
- fluanisone [MeSH Supplementary Concept]
- flupenthixol [MeSH Descriptor]
- fluperlapine [MeSH Supplementary Concept]
- fluphenazine [MeSH Descriptor]
- fluphenazine depot [MeSH Supplementary Concept]
- fluphenazine enanthate [MeSH Supplementary Concept]
- fluspirilene [MeSH Descriptor]
- haloperidol [MeSH Descriptor]
- haloperidol decanoate [MeSH Supplementary Concept]
- iloperidone [MeSH Supplementary Concept]
- isofloxythepin [MeSH Supplementary Concept]
- lithium [MeSH Descriptor]
- loxapine [MeSH Descriptor]
- lysergol [MeSH Supplementary Concept]
- mesoridazine [MeSH Descriptor]
- methiothepin [MeSH Descriptor]
- methotrimeprazine [MeSH Descriptor]
- metylperon [MeSH Supplementary Concept]
- molindone [MeSH Descriptor]
- nemonapride [MeSH Supplementary Concept]
- norclozapine [MeSH Supplementary Concept]
- ondansetron [MeSH Descriptor]
- penfluridol [MeSH Descriptor]
- perazine [MeSH Descriptor]
- perospirone [MeSH Supplementary Concept]
- perphenazine [MeSH Descriptor]
- piflutixol [MeSH Supplementary Concept]
- pimavanserin [MeSH Supplementary Concept]
- pimozide [MeSH Descriptor]
- pipamperone [MeSH Supplementary Concept]
- prochlorperazine [MeSH Descriptor]
- promazine [MeSH Descriptor]
- raclopride [MeSH Descriptor]
- remoxipride [MeSH Descriptor]
- reserpine [MeSH Descriptor]
- rimcazole [MeSH Supplementary Concept]
- risperidone [MeSH Descriptor]
- ritanserin [MeSH Descriptor]
- sertindole [MeSH Supplementary Concept]
- spiperone [MeSH Descriptor]
- stepholidine [MeSH Supplementary Concept]
- sulforidazine [MeSH Supplementary Concept]
- sulpiride [MeSH Descriptor]
- tetrahydropalmatine [MeSH Supplementary Concept]
- thioridazine [MeSH Descriptor]
- thiothixene [MeSH Descriptor]
- tiapride hydrochloride [MeSH Descriptor]
- timiperone [MeSH Supplementary Concept]
- trifluoperazine [MeSH Descriptor]
- trifluperidol [MeSH Descriptor]
- triflupromazine [MeSH Descriptor]
- veralipride [MeSH Supplementary Concept]
- zetidoline [MeSH Supplementary Concept]
- ziprasidone [MeSH Supplementary Concept]
- zotepine [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anti-psychotic agent (substance) [SNOMED CT concept]
- Antipsychotic Agent [NCIt concept]
- Antipsychotics [LOINC component]
- Antipsychotics [neuroleptics] [Bloc CIM-11]
- Medicinal product acting as antipsychotic agent (product) [SNOMED CT concept]
- anti-psychotic agent, nos [SNOMED Notion]
- antipsychotics [ATC Code]
- antipsychotics [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients